Melphalan hydrochloride

盐酸美法仑

Report date: 2022/03/23 17:21:45
NME

Base Information

Drug NameMelphalan hydrochloride
Drug Alias NameEvomelaAlkeran
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsUveal melanomaOvarian NeoplasmsBreast Neoplasms +[11
Global Approved IndicationsMultiple Myeloma
Approved Indications in ChinaMultiple Myeloma
Original Approved Country/TerritoryCanada
Original Approved Date1963/09/26
Country/TerritoryCanadaUnited StatesSweden +[8
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApotex
China Registration ClassN/A

Develop Information

Active IndicationsUveal melanomaOvarian NeoplasmsBreast Neoplasms +[10
Inactive IndicationsImmunoglobulin Light-chain Amyloidosis

Other Information

ATC CodeL01AA03